HSandM Magazine

Menu
  • Home
  • About
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
    • Why I Work in Healthcare
  • Submit an Innovation!
  • Advertise
  • Agency Directory
  • FREE SUBSCRIPTION!
Menu

HSandM Magazine

Search

Sep/Oct2015

Latest stories

15 Shares

How Are You Doing $alary-Wise?

The Pharmacy as a Media Channel

17 Shares

Diversity: What Is It, And How Do You Get There?

More stories

  • in Industry Trends

    7 Ways to Build Relationships in Medical Device Sales

    by hsandm September 1, 2015, 12:00 pm

  • in Executive Spotlight

    Denice Torres: Being True to Yourself

    by hsandm September 1, 2015, 12:00 pm

  • in Innovation Showcase

    5 Steps To An Optimal Customer Experience

  • in Industry Trends

    Diversity In Detail

    by hsandm September 1, 2015, 12:00 pm

  • in Industry Trends

    Today’s and Tomorrow’s Leaders

    by hsandm September 1, 2015, 12:00 pm

  • in Industry Trends

    BY THE NUMBERS

    by hsandm September 1, 2015, 12:00 pm

  • in Round Table

    MEET OUR EXECUTIVE PANEL:

    by hsandm September 1, 2015, 12:00 pm

  • in Innovation Showcase

    Experimenting in the Commercial Investment Lab

    by hsandm September 1, 2015, 12:00 pm

  • in Top Industry Lists

    HSM TOP 50 MEDICAL DEVICE COMPANIES

  • in Industry Trends

    HS & M the publication for healthcare sales & marketing leaders ™

    by hsandm September 1, 2015, 12:00 pm

  • in Round Table

    THERE ARE SOME THINGS PEOPLE JUST WON’T TELL YOU BUT THEY’LL TELL US IN CONFIDENCE. AND WE’LL TELL YOU.

    by hsandm September 1, 2015, 12:00 pm

Trending Now

  • Headlines

    649 Views0 Comments

    in Headlines

    Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing

    Menlo Park, CA., June 22, 2022 (GLOBE NEWSWIRE) — Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, announced today the closing of a $119 million financing round led by Enavate Sciences, a portfolio company created by Patient Square Capital. Additional investors participating in the financing include Alladapt’s founding investor, Gurnet Point Capital, along with new investors Allerfund, Novartis (NYSE: NVS), Red Tree Venture Capital, and WestRiver Group. More

    by hsandm June 22, 2022, 4:56 pm

    Read More

  • Headlines

    393 Views0 Comments

    in Headlines

    Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer

    Cambridge, MA, June 22, 2022 (PRNewswire) — Angiex, developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, has appointed Marty J. Duvall as chief executive officer and member of its board of directors. More

    by hsandm June 22, 2022, 4:24 pm

    Read More

  • Headlines

    745 Views0 Comments

    in Headlines

    Inimmune’s new CEO Alan Joslyn takes the helm

    Missoula, MT., June 21, 2022 (PRNewswire) — Inimmune Corp., a leader in developing the next generation of vaccines and immunotherapeutics, announced today that Dr. Alan Joslyn has been appointed President and Chief Executive Officer of the company. Dr. Joslyn will also join the Inimmune Board of Directors as CEO. More

    by hsandm June 21, 2022, 4:50 pm

    Read More

  • Headlines

    2 Shares492 Views0 Comments

    in Headlines

    Precision BioSciences and Novartis ink 1.5B In Vivo Gene Editing Collaboration

    Durham, N.C. June 21, 2022 (BUSINESS WIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced it has entered into an exclusive worldwide in vivo gene editing research and development collaboration and license agreement with Novartis Pharma AG (the “Agreement”). As part of the Agreement, Precision will develop a custom ARCUS nuclease that will be designed to insert, in vivo, a therapeutic transgene at a “safe harbor” location in the genome as a potential one-time transformative treatment option for diseases including certain hemoglobinopathies such as sickle cell disease and beta thalassemia. More

    by hsandm June 21, 2022, 4:17 pm

    Read More

  • Headlines

    8 Shares869 Views0 Comments

    in Headlines

    Israel’s Aidoc raises $110m for AI tech that reads imaging scans

    New York, NY, June 20, 2022 (The Times of Israel) — Aidoc, a maker of AI-based software that helps radiologists read medical scans and alerts them to strokes or pulmonary embolisms, has pulled in a $110 million Series D investment round to expand the development of its technology, sales and its market reach, the company said last week. More

    by hsandm June 20, 2022, 4:47 pm

    Read More

  • Headlines

    11 Shares993 ViewsComments Off on Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

    in Headlines

    Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

    Philadelphia, PA.,  June 8, 2022 (PRNewswire) — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for the treatment of hypertension, today announced the completion of an oversubscribed and up-sized $118 million Series B financing. More

    by hsandm June 8, 2022, 7:47 pm

    Read More

Categories

  • Agency Directory
  • Digital Magazine
  • Editorial Board
  • Executive Spotlight
  • Great Minds
  • Headlines
  • Industry Trends
  • Innovation Showcase
  • Leadership
  • Motivideos
  • Round Table
  • Talent Trends
  • Top Industry Lists
  • Uncategorized
  • Why I Work in Healthcare

© 2022 by CL Media, Inc.

  • Home
  • Contact us
  • Privacy Policy
  • Terms of Use
  • Sign Up!
Back to Top
Close
  • Home
  • About
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
    • Why I Work in Healthcare
  • Submit an Innovation!
  • Advertise
  • Agency Directory
  • FREE SUBSCRIPTION!
  • facebook
  • twitter
  • instagram
  • pinterest
  • youtube

Log In

Sign In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.